TrialJCO precision oncology2025

Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With Cemiplimab.

Javier Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.